Taiwan FDA registration ccd4c02e21f43013cfc26de03ce61786

LZI Amphetamines 500 EIA Kit

TW: 靈芝安非他命酵素免疫試劑
Taiwan flagTaiwan·Risk Class 2·MD·LIN-ZHI INTERNATIONAL, INC·Registered Aug 15, 2018 – Aug 15, 2023Expired
Registration details
Analysis ID
ccd4c02e21f43013cfc26de03ce61786
License Form
Ministry of Health Medical Device Import No. 031423
Customs Code
DHA05603142304
Company information
Manufacturer Country
United States
Product details
Intended Use
This product is used for the qualitative or semi-quantitative determination of amphetamines and methamphetamines in human urine and must be used with an automated biochemical analyzer with a threshold of 500ng/mL (corrected by d-methamphetamine).
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A3100 Amphetamine Test System
Import Information
Imported from abroad
Dates and status
Registration Date
Aug 15, 2018
Expiry Date
Aug 15, 2023
Companies making similar products

Top companies providing products similar to "LZI Amphetamines 500 EIA Kit"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for LZI Amphetamines 500 EIA Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ccd4c02e21f43013cfc26de03ce61786 and manufactured by LIN-ZHI INTERNATIONAL, INC. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including LIN-ZHI INTERNATIONAL, INC, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations